Access

You are not currently logged in.

Access your personal account or get JSTOR access through your library or other institution:

login

Log in to your personal account or through your institution.

If You Use a Screen Reader

This content is available through Read Online (Free) program, which relies on page scans. Since scans are not currently available to screen readers, please contact JSTOR User Support for access. We'll provide a PDF copy for your screen reader.

Synthetic Analogues of Migrastatin That Inhibit Mammary Tumor Metastasis in Mice

Dandan Shan, Lin Chen, Jon T. Njardarson, Christoph Gaul, Xiaojing Ma, Samuel J. Danishefsky and Xin-Yun Huang
Proceedings of the National Academy of Sciences of the United States of America
Vol. 102, No. 10 (Mar. 8, 2005), pp. 3772-3776
Stable URL: http://www.jstor.org/stable/3374811
Page Count: 5
  • Read Online (Free)
  • Subscribe ($19.50)
  • Cite this Item
Since scans are not currently available to screen readers, please contact JSTOR User Support for access. We'll provide a PDF copy for your screen reader.
Synthetic Analogues of Migrastatin That Inhibit Mammary Tumor Metastasis in Mice
Preview not available

Abstract

Tumor metastasis is the most common cause of death in cancer patients. Here, we show that two, fully synthetic migrastatin analogues, core macroketone and core macrolactam, are potent inhibitors of metastasis in a murine breast tumor model. Administration of these readily accessible compounds nearly completely inhibits lung metastasis of highly metastatic mammary carcinoma cells. Treatment of tumor cells with core macroketone and core macrolactam blocks Rac activation, lamellipodia formation, and cell migration, suggesting that these chemical compounds interfere with the invasion step of the metastatic process. These compounds also inhibit the migration of human metastatic breast cancer cells, prostate cancer cells, and colon cancer cells but not normal mammary-gland epithelial cells, fibroblasts, and leukocytes. These data demonstrate that the macroketone and macrolactam core structures are specific small-molecule inhibitors of tumor metastasis. These compounds or their analogues could potentially be used in cancer-therapy strategies.

Page Thumbnails

  • Thumbnail: Page 
[3772]
    [3772]
  • Thumbnail: Page 
3773
    3773
  • Thumbnail: Page 
3774
    3774
  • Thumbnail: Page 
3775
    3775
  • Thumbnail: Page 
3776
    3776